These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Importance of the use of the appropriate pharmacokinetic model to analyze in vivo enzyme constants. Sedman AJ; Wagner JG J Pharmacokinet Biopharm; 1974 Apr; 2(2):161-73. PubMed ID: 4427220 [No Abstract] [Full Text] [Related]
3. Computers, models, and optimization in physiological kinetics. Johnson LE CRC Crit Rev Bioeng; 1974 Feb; 2(1):1-37. PubMed ID: 4594861 [No Abstract] [Full Text] [Related]
5. Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug. Smolen VF J Pharm Sci; 1971 Mar; 60(3):354-65. PubMed ID: 5572111 [No Abstract] [Full Text] [Related]
6. Intravascular lidocaine compartment: kinetics of bolus injection. De Jong RH; Heavner JE; De Oliveira L Anesthesiology; 1972 Nov; 37(5):493-7. PubMed ID: 5079303 [No Abstract] [Full Text] [Related]
7. [Pressing problems of pharmacokinetics]. Lakin KM; Krylov IuF; Gor'kov VA Farmakol Toksikol; 1980; 43(1):5-16. PubMed ID: 6991282 [No Abstract] [Full Text] [Related]
8. Importance of biopharmaceutics and pharmacokinetics in clinical medicine. Cabana BE Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and pharmacokinetics of naloxone. Weinstein SH; Pfeffer M; Schor JM Adv Biochem Psychopharmacol; 1973; 8(0):525-35. PubMed ID: 4794980 [No Abstract] [Full Text] [Related]
10. Transfer functions obtained by the rule of corresponding fractional areas. Dost FH; von Hattingberg HM Eur J Clin Pharmacol; 1971 Sep; 3(4):252-4. PubMed ID: 5151310 [No Abstract] [Full Text] [Related]
11. [Pharmacokinetic models]. Dahl S Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373 [No Abstract] [Full Text] [Related]
12. An overview of the analysis and interpretation of bioavailability studies in man. Wagner JG Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of drugs administered intravenously. Hug CC Anesth Analg; 1978; 57(6):704-23. PubMed ID: 367214 [No Abstract] [Full Text] [Related]
14. [A pharmacokinetic function for galenics]. Dost FH Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699 [No Abstract] [Full Text] [Related]
15. Bioavailability and pharmacokinetic analysis of drug responding systems. Smolen VF Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066 [No Abstract] [Full Text] [Related]
16. Pharmacokinetic profile of coumermycin A. Kaplan SA J Pharm Sci; 1970 Mar; 59(3):309-13. PubMed ID: 5416168 [No Abstract] [Full Text] [Related]
17. The simulation of the elimination process for a substance injected into the blood stream. Hallberg D; McLean A Acta Med Scand; 1973; 194(3):173-9. PubMed ID: 4746525 [No Abstract] [Full Text] [Related]
18. [Pharmacokinetics and biopharmaceutics of intravenous administration]. Casiglia E; Gava R; Giacomello M G Clin Med; 1988 Mar; 69(3):217-20. PubMed ID: 3169450 [No Abstract] [Full Text] [Related]
19. OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics. Kelman AW; Whiting B; Bryson SM Br J Clin Pharmacol; 1982 Aug; 14(2):247-56. PubMed ID: 7104175 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics after oral and intravenous administration of tetracycline compounds (author's transl)]. Dimmling T; Vanderbeke O Med Klin; 1975 Feb; 70(7):279-85. PubMed ID: 804588 [No Abstract] [Full Text] [Related] [Next] [New Search]